Also published in GlobeNewswire:
NACD Directorship 100 Forum Focused on Reinvigorating America
x hide permanently

Grace Colón Succeeds Amy Abernethy on the CareDx Board

GlobeNewswire

(GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Grace Colón, Ph.D. has joined CareDx's Board of Directors...

Mentions: Investor Relations Nasdaq Executive Chairman